Β-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor.

•Rate of paradoxical hypotension not increased by β-adrenergic agonists in carcinoid.•Severity of intraoperative hypotension not worsened by β-adrenergic agonists.•Hypotension duration not increased by β-adrenergic agonists.•No increase in postoperative complications with β-adrenergic agonists.